Skip to main content
. 2020 Sep 25;29(3):169–175. doi: 10.1136/ejhpharm-2020-002425

Table 1.

Standard Protocol Items: Recommendation for Interventional Trials (SPIRIT)

Study period
Hospital stay Hospital discharge Follow-up Close-out
TIME POINT 1 to −7 days 0 M3 M6 M9 M12
ENROLMENT
Eligibility screen X
Informed consent X
INTERVENTIONS
Medication reconciliation X*
Medication review X
Interview before discharge X*
Providing educational brochures, discharge plan, medication plan X*
Providing follow-up diary X
Information sharing with healthcare professionals X* X* X* X* X*
Telephone interviews X* X* X*
Final interview X
ASSESSMENTS
History, demographics X
PRIMARY OUTCOME
Medication possession ratio X* X* X* X
Adherence scale X X
SECONDARY OUTCOMES
Blood glucose control X X
Lipid control X X
Abdominal girth X X
Blood pressure X X
Quality of life (SF-36) X X
Belief/representation about the disease (Brief IPQR) X X
Knowledge about the disease and the treatments X X
Lifestyle X X
Number, type and severity of iatrogenic events X
Proportion of patients having recurrent stroke or other major adverse cardiovascular event X
Proportion of patients readmitted to hospital X
Adherence to each secondary preventive drug X
Patient satisfaction regarding treatments (SATMED-Q) X
Patient satisfaction regarding the intervention programme X*
Community pharmacist’s satisfaction regarding the intervention programme X*
General practitioner’s satisfaction regarding the intervention programme X*

*Intervention group.

Brief IPQR, Brief Illness Perception Questionnaire; SATMED-Q, Treatment Satisfaction with Medicines Questionnaire; SF-36, Short Form 36 Health Survey questionnaire.